FDA Approves Daily Pill to Treat Low Libido in Women After Menopause

Health & LifestyleNews
796

Listen to article (english)

Translate to Spanish or other 102 languages!

On December 15, 2025, the U.S. Food and Drug Administration (FDA) approved the medication Addyi (flibanserin) for the treatment of hypoactive sexual desire disorder (HSDD) in postmenopausal women under the age of 65. Image for illustration purposes
On December 15, 2025, the U.S. Food and Drug Administration (FDA) approved the medication Addyi (flibanserin) for the treatment of hypoactive sexual desire disorder (HSDD) in postmenopausal women under the age of 65. Image for illustration purposes

Mega Doctor News

- Advertisement -

Medical News Today

On December 15, 2025, the U.S. Food and Drug Administration (FDA) approved the medication Addyi (flibanserin) for the treatment of hypoactive sexual desire disorder (HSDD) in postmenopausal women under the age of 65.

Addyi was previously approved in 2015 for the treatment of HSDD in premenopausal women. Premenopause or “before” menopause refers to the reproductive time in a cisgender woman’s life when they have regular menstrual cycles.

- Advertisement -

Follow the link below to Medical News Today to read the full story:

https://www.medicalnewstoday.com/articles/fda-approves-daily-pill-treat-low-libido-women-postmenopause-explainer?utm_term=feature&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2025-12-19&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

Information source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Heart Association Highlights 2025’s Major Research Findings
Next article
From Patient to Hero: Isaac Garza Delivers 2,089 Smiles This Holiday Season

More Articles

How Energy Drinks Can Mask the Dangers of Alcohol

As students prepare for the start of the fall semester, experts with the New Jersey Poison Control Center are warning about the dangers of mixing energy drinks with alcohol.

Prepping for Fall Allergy Season

Even though summer isn’t over just yet, it’s already about time to start thinking about fall allergies.

Newsweek Recognizes STHS Among America’s Top Midsize Employers

Midsize companies play a critical role in the U.S. economy, serving as a powerful engine for innovation, job creation and economic growth. 

DHR Health’s Free Community Education Seminar on Adult Epilepsy, Aug. 15th

 DHR Health, together with the Epilepsy Foundation Central and South Texas, will host a free community health education seminar that will focus on epilepsy and supporting adults living with the condition
- Advertisement -